SCHEMBL19107583

SCHEMBL19107583

Cc1ccc(COc2ccc(CCCCCCCCc3ccccc3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.66
▸ EPHX2 P34913 1/20 0.66
▸ MGLL Q99685 2/20 0.62
▸ BCHE P06276 4/20 0.61
▸ SIGMAR1 Q99720 1/20 0.56
▸ FFAR1 O14842 1/20 0.55
▸ FFAR4 Q5NUL3 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ DRD2 P14416 1/20 0.55
▸ DRD4 P21917 1/20 0.55
▸ DRD3 P35462 1/20 0.55
▸ LMNA P02545 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ PTGS1 P23219 1/20 0.53
▸ SLC6A2 P23975 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ PTGS2 P35354 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ HIF1A Q16665 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12040562 0.91 LTA4H (0.77) LTA4HEPHX2MGLLBCHEFFAR1
SCHEMBL12630258 0.91 LTA4H (0.77) LTA4HEPHX2MGLLBCHEFFAR1
SCHEMBL128703 0.88 LMNA (0.67) BCHEL3MBTL1LMNACYP1A2PTGS1
SCHEMBL6284506 0.87 LTA4H (0.66) LTA4HEPHX2MGLLBCHESIGMAR1
SCHEMBL11051776 0.87 LTA4H (0.66) LTA4HEPHX2MGLLBCHESIGMAR1
SCHEMBL13979617 0.86 DRD2 (0.62) FFAR1TDP1L3MBTL1DRD2DRD4
SCHEMBL6283332 0.85 LTA4H (0.68) LTA4HEPHX2MGLLBCHESIGMAR1
SCHEMBL12040563 0.85 HRH3 (0.61) LTA4HEPHX2BCHELMNAPTGS1
SCHEMBL257764 0.84 DRD2 (0.64) FFAR1TDP1L3MBTL1DRD2DRD4
SCHEMBL11611966 0.84 LMNA (0.58) LTA4HEPHX2BCHEL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170196854-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS INTERVET INC. (US) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170196854-A1 USE OF ANTHELMINTIC AGENTS AGAINST DIROFILARIA IMMITIS MPO, DHODH, DHX35 LTA4H 149/4885EPHX2 340/4885MGLL 940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback